17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice.
M. Yatomi (Maebashi, Japan), T. Hisada (Maebashi, Japan), Y. Hachisu (Maebashi, Japan), Y. Tsukagoshi (Maebashi, Japan), N. Kasahara (Maebashi, Japan), M. Sato (Maebashi, Japan), H. Tsurumaki (Maebashi, Japan), H. Saito (Maebashi, Japan), K. Hara (Maebashi, Japan), Y. Koga (Maebashi, Japan), N. Sunaga (Maebashi, Japan), T. Maeno (Maebashi, Japan), K. Dobashi (Maebashi, Japan)
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Yatomi (Maebashi, Japan), T. Hisada (Maebashi, Japan), Y. Hachisu (Maebashi, Japan), Y. Tsukagoshi (Maebashi, Japan), N. Kasahara (Maebashi, Japan), M. Sato (Maebashi, Japan), H. Tsurumaki (Maebashi, Japan), H. Saito (Maebashi, Japan), K. Hara (Maebashi, Japan), Y. Koga (Maebashi, Japan), N. Sunaga (Maebashi, Japan), T. Maeno (Maebashi, Japan), K. Dobashi (Maebashi, Japan). 17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice.. 3709
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011
Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008
Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019
Attenuation of bleomycin-induced pulmonary fibrosis by direct thrombin inhibition is accompanied by a reduction in connective tissue growth factor mRNA levels Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001
Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005
6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020
Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019
TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019 Year: 2020
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020
c-Met expression induction in immune cells modulates pulmonary fibrosis progression Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020
Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007
Gp130-Stat3 signalling regulates sensitivity to bleomycin induced lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006
Overexpression of ISCU can extenuate mitochondrial damage, reduce EMT and bleomycin-induced pulmonary fibrosis Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020
Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018
Role of MyD88 in cigarette-smoke induced pulmonary cell recruitment in mice Source: Eur Respir J 2005; 26: Suppl. 49, 343s Year: 2005